Mekinist Európska únia - chorvátčina - EMA (European Medicines Agency)

mekinist

novartis europharm limited - trametinib - melanoma - antineoplastična sredstva - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 i 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. Немелкоклеточный rak pluća (НМРЛ)trametinib u kombinaciji s dabrafenib indiciran za liječenje odraslih bolesnika s preliminarnim non-mali raka pluća stanice s Браф mutacija v600 daleko .

MEKINIST 0.5mg Film tableta Čierna Hora - chorvátčina - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

mekinist 0.5mg film tableta

"novartis pharma services ag" dio stranog druŠtva podgorica - trametinib - film tableta - 0.5mg

MEKINIST 2mg Film tableta Čierna Hora - chorvátčina - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

mekinist 2mg film tableta

"novartis pharma services ag" dio stranog druŠtva podgorica - trametinib - film tableta - 2mg